AMDS partners and stakeholders meeting 2011
Date: 28-29 March 2011
Place: Geneva, Switzerland
The three main objectives of the meeting
- To take stock of progress and achievements made on current major projects which aim at increasing access to ARV, TB and malaria treatments and diagnostics.
- To share and discuss current achievements, challenges and way forward to prevent stock outs and overstocks.
- To identify priority activities that partners expect AMDS to focus on, how to improve the working mechanism of the network and the type of support that AMDS could expect from the partner network.
Strengthening procurement and supply management (PSM) of AIDS medicines and diagnostics (AMD) in developing countries requires effective partnership at global, regional and country levels. The AMD Network, composed of over 25 partners and stakeholders, has been established for this purpose and has recently undertaken the integration of some PSM areas (e.g. GPRM, PSM Toolbox, PSM early warning indicators) related to TB and malaria medicines in collaboration with relevant WHO Departments. Significant progress has been made in various procurement and supply management (PSM) projects including Global Price Reporting Mechanism, Forecasting of global ARVs demand, prequalification and Medicine Market and Transparency, PSM Early warning indicators to prevent stock out and overstock of ARVs, TB & malaria medicines, capacity building for strengthening PSM systems, PSM Toolbox, Coordinated Procurement Planning, Medicines patent pool, Voluntary Pooled procurement, national laboratory strategic planning, the Country Profile for Pharmaceuticals and Health Products Management, etc.
However, partners and stakeholders are still facing PSM challenges at global as well as at country levels which need to be discussed at regular basis to be tackled more effectively. AMD partners and stakeholders meet annually to share PSM experiences and to identify PSM priorities on which effective collaboration can be engaged to improve the supply chain management at global and country levels.
Access to HIV treatment
The Medicines Patent Pool by Esteban Burrone
New ARV combinations uptake in PEPFAR countries and cost implications by WHO
From '3 by 5' to Treatment 2.0: Catalyzing the next phase of treatment, care and support by WHO
The Global Price Reporting Mechanism by WHO
Laboratory strengthening to diagnostics
Access to diagnostic monitoring laboratory services at point of care through implementation of national laboratory strategic planning: PEPFAR experience by CDC
Procurement of diagnostics and laboratory equipment by WHO
Specification of laboratory items for effective procurement of lab items: lessons, current status and proposed way forward by WHO
Prevention of stockouts and overstocks
Preventing stock-outs and treatment disruptions in Global Fund-supported programs by the Global Fund
Improving access to data to support timely decision making to prevent stock outs: country case studies by USAID
Major PSM factors leading to stock outs and impact of implementation of PSM EWI on ARVs and TB medicines, country case study by Zimbabwe Ministry of Health